| In-vitro parameters (n=31, ∗n=30) | Oh-SDP Mean±SD | 2h-SDP Mean±SD | P-value |
|---|---|---|---|
| HSR day 5 (%) | 64.8±10.0 | 64.7±12.0 | 0.969 |
| HSR day 7 (%) | 59.9±10.7 | 60.2±10.6 | 0.883 |
| ESC day 5 (%) | 24.4±4.8 | 25.2±4.8 | 0.334 |
| ESC day 7 (%) | 20.3±4.4 | 19.6±4.9 | 0.377 |
| CD62P day 5 (%)∗ | 2.03±1.02 | 2.02±0.88 | 0.938 |
| CD62P day 7 (%) | 3.03±1.26 | 2.99±1.23 | 0.844 |
| MPV day 5 (fl) | 7.83±0.51 | 7.84±0.54 | 0.904 |
| MPV day 7 (fl) | 7.98±0.50 | 7.99±0.53 | 0.742 |
| pH at 22°C day 5 | 7.47±0.07 | 7.47±0.07 | 0.685 |
| pH at 22°C day 7 | 7.49±0.09 | 7.48±0.09 | 0.511 |
| Glucose utilization until day 7 (mmol/day/1011 PLTs) | 0.31±0.07 | 0.31±0.08 | 0.648 |
| Lactate increase until day 7 (mmol/day/1011 PLTs) | 0.63±0.11 | 0.62±0.13 | 0.582 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.